We only have this paper's title and publication details.
Read it at the sourceObservational analysis evaluates safety and feasibility of S-1 after capecitabine toxicity in colon cancer patients, suggesting potential for improved outcomes.
No takes yet. Share an insight, caveat, or question.
Ghedri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: